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http://www.biomedcentral.com/1471-2342/12/14RESEARCH ARTICLE Open AccessAn alternative method for quantifying coronary
artery calcification: the multi-ethnic study of
atherosclerosis (MESA)
C Jason Liang1, Matthew J Budoff2, Joel D Kaufman3, Richard A Kronmal1 and Elizabeth R Brown1,4*Abstract
Background: Extent of atherosclerosis measured by amount of coronary artery calcium (CAC) in computed
tomography (CT) has been traditionally assessed using thresholded scoring methods, such as the Agatston score
(AS). These thresholded scores have value in clinical prediction, but important information might exist below the
threshold, which would have important advantages for understanding genetic, environmental, and other risk factors
in atherosclerosis. We developed a semi-automated threshold-free scoring method, the spatially weighted calcium
score (SWCS) for CAC in the Multi-Ethnic Study of Atherosclerosis (MESA).
Methods: Chest CT scans were obtained from 6814 participants in the Multi-Ethnic Study of Atherosclerosis (MESA).
The SWCS and the AS were calculated for each of the scans. Cox proportional hazards models and linear regression
models were used to evaluate the associations of the scores with CHD events and CHD risk factors. CHD risk factors
were summarized using a linear predictor.
Results: Among all participants and participants with AS > 0, the SWCS and AS both showed similar strongly
significant associations with CHD events (hazard ratios, 1.23 and 1.19 per doubling of SWCS and AS; 95% CI, 1.16 to
1.30 and 1.14 to 1.26) and CHD risk factors (slopes, 0.178 and 0.164; 95% CI, 0.162 to 0.195 and 0.149 to 0.179). Even
among participants with AS = 0, an increase in the SWCS was still significantly associated with established CHD risk
factors (slope, 0.181; 95% CI, 0.138 to 0.224). The SWCS appeared to be predictive of CHD events even in
participants with AS = 0, though those events were rare as expected.
Conclusions: The SWCS provides a valid, continuous measure of CAC suitable for quantifying the extent of
atherosclerosis without a threshold, which will be useful for examining novel genetic and environmental risk factors
for atherosclerosis.Background
Coronary artery calcium (CAC) as detected by com-
puted tomography (CT) is a known marker of subclin-
ical atherosclerosis [1,2] and is a powerful predictor of
the risk of coronary events [3-16]. Most commonly, the
Agatston, mass, and volume scores have been used to
quantify the amount of CAC [17-20].
The Multi-Ethnic Study of Atherosclerosis (MESA), a
prospective study with 6814 participants free of* Correspondence: elizab@uw.edu
1Department of Biostatistics, University of Washington, Seattle, WA, USA
4Vaccine and Infectious Disease and Public Health Sciences Divisions, Fred
Hutchinson Cancer Research Center, Seattle, WA, USA
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reproduction in any medium, provided the orcardiovascular disease (CVD) at baseline, was designed to
include CT scanning at 4 time points (with two scans per
individual at each time point). The CVD exclusion was for
those with known clinical disease, and based on self-
reported information. The CT reading protocol used a
conservative algorithm for lesion detection with high spe-
cificity for detection of lesions at the sacrifice of sensitivity.
Any voxels not meeting the lesion definition in the algo-
rithm were not used in calculating CAC scores. As such,
participants early in the disease progression stages with
small calcifications that showed up on the CT scan as less
than four contiguous voxels or 130 Hounsfield units (HU)
may have been classified as having an undetectable level
of CAC. Roughly 50% of the participants in the MESA co-
hort received a zero CAC score while almost certainlytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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calcified atherosclerotic lesions. This classification as
“zero” has a small impact on our ability to identify indivi-
duals at high risk of a coronary event since the high
threshold is still adequately sensitive for risk prediction;
however, having excess zeros due to misclassification ad-
versely impacts our ability to use CAC measures for mod-
eling and understanding subclinical disease extent and
progression.
An ancillary study in MESA focused on ambient air pol-
lution exposures in cohort members is studying the effect
of pollutant concentrations on progression of atheroscler-
osis over 10 years of follow-up [21]. While the relationship
between air pollution exposure and CAC is a wholly dif-
ferent question not pursued in this study, it was a motivat-
ing factor in developing a valid scoring method to
quantify CAC extent throughout the range of detected
calcium. More specifically, there are multiple reasons to
explore new approaches to quantifying CAC in the MESA.
First, current scoring techniques ignore much of the infor-
mation available in the CT scan that may prove useful in
identifying calcified lesions. Second, many of the partici-
pants with an Agatston Score (AS) of zero may have had
CAC present that did not meet the definition for CAC on
the image. Therefore, current CAC measures can fall short
as measures of subclinical disease burden while very suc-
cessfully serving as surrogates for risk of clinical events.
Third, the high proportion of zero scores complicates ana-
lysis of CAC data. We thus propose an alternative score,
the spatially weighted calcium score (SWCS), that uses
spatial information in the image combined with voxel-
specific weights derived from the phantom, thereby mak-
ing use of more of the information in the CT scans and
also providing a continuous measure of CAC.
Methods
Data collection
The MESA was established to study the prevalence, pro-
gression, and risks of subclinical cardiovascular disease.
Details of the study design have been previously pub-
lished [22]. A cohort of 6814 men and women, aged 45–
84, without known clinical cardiovascular disease was
recruited between July 2000 and September 2002 from
six urban communities (Baltimore City and Baltimore
County, Maryland; Chicago, Illinois; Forsyth County,
North Carolina; Los Angeles County, California; New
York, New York; and St. Paul, Minnesota). Each of the
six centers recruited a population-based sample while
oversampling blacks, Chinese, and Hispanics based on
self-reported ethnicity at time of enrollment. Institu-
tional review boards at each site approved the study, and
all participants gave written informed consent. Further
documentation regarding data collection and protocols
can be found at www.mesa-nhlbi.org [23].Risk factors
Information about risk factors and demographics was
obtained at enrollment and during the baseline examin-
ation. Participants were given questionnaires to obtain
information about tobacco usage, passive smoke expos-
ure, alcohol use, medical conditions, medical care access,
family history of CVD, reproductive history, and medica-
tion use and history. Physical activity was measured
using a questionnaire from the Cross-Cultural Activity
Participation Study; diet was measured using a modified
version of the Insulin Resistance Atheroslecrosis study
instrument; anger and anxiety were measured using
questionnaires administered on the Spielberger trait
anger and anxiety scales; depression was measured on
the Center for Epidemiologic Studies Depression scale.
Height, weight, and waist and hip circumferences were
measured. Blood pressure was measured three times
using an automated oscillometric sphygmomanometer
(Dinamap Pro 1000; Critikon, Tampa, Florida). Blood
samples were taken after a 12-hour fast, and were ana-
lyzed by a central laboratory at the University of Ver-
mont for many different measurements including total
cholesterol, lipids and lipoproteins (including HDL and
LDL), insulin resistance, plasma glucose, triglycerides,
high-sensitivity C-reactive protein, and creatinine mea-
surements. Diabetes was defined as use of insulin or oral
hypoglycemic agents, or fasting glucose of 126 mg/dL
or greater. Body-mass index was defined as weight in
kilograms divided by the square of height in meters.
Documentation further detailing the questionnaire and
measurement protocols can be found at www.mesa-
nhlbi.org [23] and Bild et al. [22].
Cardiovascular events (follow-up)
We followed all participants for cardiovascular events
for an average of 6.0 years. Interviewers called each par-
ticipant at intervals of 9–12 months to obtain informa-
tion about new CVD conditions, CVD interventions,
hospitalizations, treatments, changes in life habits, and
death. Detailed descriptions of MESA events definitions
and follow-up procedure have been previously published
[11,15]. For our analyses, we separately considered any
CHD (definite or probable myocardial infarction, definite
CHD death, or definite or probable angina) and hard
CHD (definite or probable myocardial infarction or def-
inite CHD death) events. We note that probable angina
cases were only classified as a CHD event if accompan-
ied with a revascularization procedure.
CT scanning
A detailed report of the CT scanning and reading proto-
col has been previously reported [24]. At the baseline
examination, each participant was given two consecutive
unenhanced chest CT scans. The Chicago, Los Angeles,
Liang et al. BMC Medical Imaging 2012, 12:14 Page 3 of 9
http://www.biomedcentral.com/1471-2342/12/14and New York sites used electron-beam CT systems
(Imatron C150; GE Medical Systems, Milwaukee, Wis-
consin), which scan at a slice thickness of 3.0 mm. The
Baltimore, Forsyth County, and St. Paul sites used multi-
detector CT systems (Lightspeed QXi, Lightspeed Plus;
GE Medical Systems, Milwaukee, Wisconsin; Volume
Zoom; Siemens, Erlangen, Germany), which scan at a
slice thickness of 2.5 mm. To allow for calibration to
compensate for inter-scan variability, radiographic phan-
toms with known densities of calcium hydroxyapatite (0,
50, 100, and 200 mg/mL) were placed beneath the
thorax of each participant for each scan. Participants
over 100 kg and at sites using multi-detector CT systems
were scanned using slightly different settings.CT scan reading
Each scan was read by one of two physician readers at
the CT reading center (Los Angeles Biomedical Research
Institute at Harbor-UCLA, Torrance, California). As
each participant received two consecutive scans, the
scans were randomized to lessen the possibility of ana-
lysts consecutively reading scans from the same partici-
pant. Reading was done using an interactive system to
identify the phantoms, determine the artery trajectories
and classify candidate calcified plaques. For all techni-
ques presented in this paper, the search for calcified
lesions was restricted to be within an 8 mm radius of
the trajectories defined by the readers. Further details
can be found in previously published reports [24].Calculation of the Agatston score
After arterial trajectories were determined and a phantom-
based adjustment was applied, candidate calcified plaques
were identified by the software with the criteria that each
plaque be composed of at least 4 contiguous voxels with
an attenuation level of 130HU or greater. The analysts
then reviewed each candidate plaque and accepted or
rejected its classification as calcified plaque.
To calculate the AS, each accepted lesion was assigned
a score by multiplying the lesion volume by a coefficient
based on its maximum HU (coefficient of 1 if maximum =
130–199, 2 if 200–299, 3 if 300–399, 4 if > = 400). The
AS is the sum of the scores across all accepted lesions. As
each participant received two scans, for purposes of this
study the average of the two Agatston scores are used for
each participant. Use of the average of two scans is
intended to reduce noise and to be consistent with meth-
ods from other MESA papers using the AS [11,15]. Fur-
ther details on the Agatston score can be found in
previously published reports [17,24]. Participants were no-
tified of their scores on the scale of no coronary calcifica-
tion, less than average, average, and greater than average.Calculation of the spatially weighted calcium score
In developing the SWCS, an important property was for
the SWCS to quantify CAC in a manner comparable to
the AS for those with AS > 0, while providing meaningful
non-zero scores for those with AS = 0. Calculation of the
SWCS started with the set of voxels identified by the
reader as representing the coronary arteries. First, we
assigned a weight to each voxel using a weighting function
with parameters derived from the scan’s phantom. The
goal of the first step was to calibrate and weight each voxel
according to the phantom so that scores across the images
were comparable. Second, each voxel was then assigned a
score depending on the weight assigned to it and its
neighbors. The goal of the second step was to use the sur-
rounding information of each voxel to obtain a more ac-
curate value, and to reduce the impact of noise by
upweighting those voxels with neighboring voxels that
had high attenuation levels and downweighting those
whose neighbors had low attenuation levels. The detailed
algorithm appears in the Additional file 1: Appendix with
illustrations of the weighting scheme.
Statistical analysis
Distributions of participant characteristics were described
using means and standard deviations. Comparisons of
these characteristics across groups were made using the t-
test. Distributions of the CAC scores were described
graphically using kernel density estimators and scatter-
plots with loess smoothers.
We used Cox proportional hazards regression models
similar to those used by Detrano et al. [11] to estimate
hazard ratios for hard CHD and any CHD events as they
relate to the SWCS and AS in all participants and the
subset with AS > 0. The models were all adjusted for
race, age, sex, smoking, diabetes, cholesterol, blood pres-
sure, lipid-lowering medication use, and antihypertensive
medication use. The AS and SWCS were transformed by
taking the base-2 logarithm after adding 1 to the score
(log2[score + 1]).
Kaplan-Meier survival curves for all CHD events were
estimated and plotted for both the SWCS and the AS.
The AS K-M curves were stratified into the following
percentiles: 0-50%, 50–62.5%, 62.5-75%, 75–87.5%, and
87.5-100%. The SWCS K-M curves were stratified simi-
larly, but with additional 0-25% and 25-50% stratifica-
tions to further evaluate any additional ordering the
SWCS may provide for participants with levels of CAC
that are undetectable by the AS.
To summarize the association between the CAC
scores and traditionally recognized CHD risk factors, we
first summarized the risk factors in a linear predictor
(LP) based on MESA data. The LP for each participant
was the sum of their covariate values multiplied by the
fitted coefficients from a Cox proportional hazards
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using all CHD events as the outcome and baseline age,
systolic blood pressure, diastolic blood pressure, total
cholesterol, HDL, diabetes, smoking, and sex as covari-
ates. The covariates were chosen based on the Framing-
ham risk variables [25,26]. We used linear regression
models to estimate the relationship of the LP with the
SWCS and AS in all participants and the subset with AS
> 0. The models were all adjusted for weight, height,
and site to accommodate different scanners across sites
and different settings used for participants over 100 kg
scanned using multi-detector CT scanners. The SWCS
and AS were transformed by taking the natural loga-
rithm after adding 1 to the score (log[score + 1]).
We used methods similar to those used by Callister
et al. [19] to assess the reproducibility of the scores. We
calculated the absolute difference between the scores of
each scan relative to their mean: x1  x2j j= x1 þ x2ð Þ=2½  
100 where x1 is the score from the first scan and x2 is the
score from the second scan. This was used as the primary
measure of reproducibility and referred to as the percent
difference for both the SWCS and AS. We also used the
intraclass correlation coefficients to assess the reproduci-
bility of the SWCS and the AS. Analyses were all done in
R version 2.11.1 [27].Results
Demographics
We compared demographics and risk factors between
those with AS = 0 and AS > 0 (Table 1). The two groups
were significantly different with respect to age, sex,
hypertension, and treated diabetes, but not for status as
a current smoker. We also bifurcated those with AS = 0
into those above and below the median based on their
SWCS, comparing demographics and risk factors be-
tween these two subgroups. The two subgroups were
significantly different with respect to sex, hypertension,
treated diabetes, and Framingham 10-year risk, but notTable 1 Demographics and risk factors
A
Characteristic SWCS 0–0.78
<50%tile
(n = 1649)
SWCS 0.7
>50%tile
(n = 165
Age (year) 57.88 58.06
Male Sex (%) 30.38% (501) 42.73% (7
Hypertension (%) 30.38% (501) 40.24% (6
Treated Diabetes (%) 4.44% (73) 10.23% (1
Current Smoker (%) 14.20% (233) 12.78% (2
Framingham 10-yr Risk (Mean [SD]) 0.080 (0.062) 0.102 (0.0
P-value is for difference between SWCS <50th percentile and SWCS >50th percent
characteristics. Framingham 10-yr Risk calculated using Circulation 1998 method.for age and current smoking status. As expected, the
SWCS of participants with AS = 0 tend to be lower than
those with AS > 0, with medians of 0.78 (range, 0.00-
284.48) versus 58.99 (range, 0.22-4262.70), respectively.
We note that while some participants had very small
SWCS, all participants had positive SWCS. A visual rep-
resentation of the relationship of the AS and SWCS
among participants with AS > 0 is shown in the Figure 1.
As suggested by the scatterplot, there is a high correl-
ation of 0.99 and the linear relationship can be summar-
ized by the equation y ¼ 0:52þ 0:67x.
CT image data was available in 6568 of the 6814 parti-
cipants. Of these, 6253 (91.8%) had image data available
for both CT scans and 315 (4.6%) for one scan. The dis-
tribution of the SWCS was quite skewed; thus we
present the smoothed density of the SWCS plus a con-
stant of 1, on the natural log scale in Figure 2. For the
6568 participants who received at least one scan, we
show the smoothed density for all participants, partici-
pants with AS > 0, and participants with AS = 0.Association of SWCS with CHD events
There were 6508 participants with available measures of all
the variables used for the events analysis. The average
follow-up time was 6.0 years, during which 291 participants
experienced a CHD event of which 171 were hard CHD
events. Among those with AS = 0, 34 participants experi-
enced a CHD event, of which 22 were hard CHD events.
An increase in the SWCS was associated with an in-
crease in risk of CHD events (Table 2). A statistically
significant relationship was observed when the model
was applied to all participants, and when restricted to
participants with AS > 0. Furthermore, the relationships
were similar to those seen when the SWCS was replaced
by the AS in the same models.
A twofold increase in the SWCS or the AS was asso-
ciated with a 23% (95% CI, 16 to 30) or 19% (95% CI, 14
to 26) increase in risk of hard CHD events, respectively.S = 0 (n = 3299) AS > 0
(n = 3269)
8-284.48
0)
P* All SWCS
0.22-4262.70
0.56 57.97 66.40
05) <0.001 36.56% (1206) 57.63% (1884)
64) <0.001 35.31% (1165) 54.70% (1788)
68) <0.001 7.33% (241) 12.83% (418)
10) 0.25 13.49% (443) 12.84% (419)
73) <0.001 0.083 (0.063) 0.137 (0.094)
ile. Calculated using t-test for age, and chi-squared tests for other
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Figure 2 Kernel density estimates of the distribution of the SWCS
are shown for AS = 0 (red), AS > 0 (blue) and all (purple).
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Figure 1 Plot of SWCS against AS for participants with AS > 0
(n = 3269).
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increase in the SWCS or AS was associated with an 18%
(95% CI, 9 to 27) or 16% (95% CI, 8 to 25) increase in
risk of hard CHD events, respectively.
When we restricted the model to only participants
with AS = 0, a twofold increase in the SWCS was asso-
ciated with a hazard ratio of 1.11 (95% CI, 0.79 to 1.51)
for hard CHD events.
The cumulative event rate and number of all CHD
events among participants grouped by different percentile
stratifications of the scores is shown in Figure 3. An ideal
risk score would have Kaplan-Meier curves that are well
separated and ordered across the quantile-based strata.
For the 75–87.5 and 87.5-100 percentile stratifications,
the SWCS and AS appear to do equally well at differenti-
ating the quantiles in terms of event risk. The 50–62.5
and 62.5-75 percentile stratifications of the SWCS separ-
ate appropriately over time, while those of the AS appearTable 2 Hazard ratios for hard and all CHD events for twofold
Hard Coronary Even
Participants CAC No. Events/No. At Risk Hazard
All Log2(AS + 1) 171/6508 1.1
Log2(SWCS + 1) 1.2
AS > 0 Log2(AS + 1) 149/3243 1.1
Log2(SWCS + 1) 1.1
AS = 0 Log2(SWCS + 1) 22/3265 1.1
Each unit increase in Log2(Score+1) represents doubling of CAC. All regressions adj
lipid-lowering medication use, and antihypertensive medication use.in the incorrect order throughout most of follow-up. That
is, that the higher quantile group has lower risk. Finally,
the 0–25 and 25–50 percentile stratifications of the SWCS
appear to demonstrate some separation, suggesting the
SWCS provides a degree of meaningful ordering of CAC
in terms of risk in the lower quantiles as well.
Association of SWCS with CHD risk factors
Among the 6510 participants with complete data for the
risk factors, an increase in the SWCS was associated with
an increase in the LP (Table 3). For all participants, on the
log(CAC + 1) scale, each unit increase in the SWCS and AS
was associated with an increase in the mean of the LP of
0.23 (95% CI, 0.22 to 0.24) and 0.18 (95% CI, 0.17 to 0.19),
respectively. For participants with AS > 0, on the log(CAC
+ 1) scale, each unit increase in the SWCS and AS was
associated with an increase in the mean of the LP of 0.18
(95% CI, 0.16 to 0.20) and 0.16 (95% CI, 0.15 to 0.18),increase in AS and SWCSs
t Any Coronary Event
Ratio (95% CI) No. Events/No. At Risk Hazard Ratio (95% CI)
9 (1.14-1.26) 291/6508 1.25 (1.20-1.30)
3 (1.16-1.30) 1.28 (1.22-1.35)
6 (1.08-1.25) 257/3243 1.24 (1.17-1.31)
8 (1.09-1.27) 1.25 (1.18-1.33)
1 (0.79-1.55) 34/3265 1.04 (0.79-1.38)
usted for race, age, sex, smoking, diabetes, cholesterol, blood pressure,
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in the log of the SWCS plus one was associated with an in-
crease in the mean of the LP of 0.18 (95% CI, 0.14 to 0.22).
For all participants, and participants with AS > 0, the
R2 values for the SWCS and AS are comparable. For parti-
cipants with AS = 0, the R2 value is 0.12. A scatterplot of
the LP against the log(SWCS + 1) for all participants is
shown in Figure 4. The dot colors represent participants
with AS = 0 or AS > 0. Smoothed curves through the
points for all participants, and the subsets of participants
with AS = 0 and participants with AS > 0 are also shown
in different colors. The vertical lines at the bottom and
top of the plot are visual aids indicating the distributions
of log(SWCS + 1) for participants with AS = 0 or AS > 0.
Reproducibility
After excluding scans judged by the scan readers to have
unacceptable levels of noise, there were 3102 participants
who had at least one scan with AS > 0. The median per-
cent difference across participants was 16.87% and 18.29%
for the SWCS and AS, respectively (Table 4). The medianTable 3 Results of linear regression of linear predictor on
SWCS and AS
Participants CAC Slope 95% CI P R2
All Log(AS + 1) 0.182 (0.174-0.190) <0.001 0.32
Log(SWCS + 1) 0.226 (0.216-0.235) <0.001 0.32
AS > 0 Log(AS + 1) 0.164 (0.149-0.179) <0.001 0.19
Log(SWCS + 1) 0.178 (0.162-0.195) <0.001 0.19
AS = 0 Log(SWCS + 1) 0.181 (0.138-0.224) <0.001 0.12
All regressions adjusted for site, weight, and height.of the percent difference in AS minus the percent differ-
ence in SWCS was 2.02% (95% CI, 1.66 to 2.40; P < 0.001).
When we performed the same analysis on the subset of
2849 participants with AS > 0 for both scans, the SWCS
still showed better reproducibility compared to the AS.0 2 4 6 8
−
3
log(SWCS+1)
Figure 4 Scatterplot of linear predictor against SWCS. This figure
plots the linear predictor against the log(SWCS +1). Red circles indicate
data points for those participants whose AS = 0, and blue indicates those
whose AS > 0. Smoothed curves are also presented to further illustrate
the association between these two measures for AS = 0 (red), AS > 0
(blue) and all (purple). The red and blue vertical lines at the bottom and
top of the plot indicate the distributions of the log(SWCS +1) for
participants with AS = 0 and AS > 0, respectively.
Table 4 Reproducibility of SWCS and AS
Participants with AS > 0 for at least one scan (n = 3102) Participants with AS > 0 for both scans (n = 2849)
Variable Median Mean Median Mean
% Change in SWCS 16.87 31.23 15.30 24.71
% Change in AS 18.29 41.52 16.26 27.38
% Change in AS minus 2.02 (1.66-2.40)* 10.31 (9.05, 11.56)* 1.05 (0.74-1.51)* 2.68 (1.99-3.36)*
% Change in SWCS
*P<0.001. P-values based on paired t-test for mean and Wilcoxon test for median.
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participants with AS < 50 (n = 892) for both scans and
AS < 100 (n = 1307) for both scans. Among these subsets
of participants with low but non-zero AS, SWCS still
showed better reproducibility.
For the participants for whom we had CT image data for
both scans (n = 6253), the intraclass correlation coefficients
for the SWCS and AS were 0.988 and 0.989, respectively.
For those with AS > 0 for both scans (n = 2849), the intra-
class correlation coefficients for the SWCS and AS were
both 0.986. For those with AS = 0 for both scans (n =
3151), the intraclass correlation coefficient for the SWCS
was 0.406.
Discussion
In this paper, we present a method for quantifying coronary
artery calcification as measured by CT that is independent
of a threshold and instead calibrated to the phantom where
the attenuation levels represent known densities. We adjust
for noise in an automated way using spatial information in
the image. The SWCS is shown to be highly related to both
risk of CHD events and traditional CHD risk factors. In
fact, it retains its strong relationship to traditional risk fac-
tors even when the AS equals zero.
Historically, interest in CAC has largely focused on its
ability as a predictor of clinical CHD events, and the AS is
an effective method of quantifying CAC for these pur-
poses. However, our approach is motivated by studies
where the primary interest in CAC is its ability to measure
atherosclerotic burden across all levels of disease. In these
cases, the AS is less suitable. Specifically, a continuous
score for CAC would be more tractable in situations
where the extent of atherosclerosis itself is of primary
interest.
The primary goal of our analysis was to validate the ef-
fectiveness of the SWCS at quantifying CAC. Unfortu-
nately, the “true” burden of CAC is unknown in the
MESA patients. Instead, we examined the association of
the SWCS with CHD events and known risk factors (via
a linear predictor).
In validating the new score, we had three objectives: 1.
Ensure that the new score does not lose any information
about subclinical disease and risk of CHD events that
the AS provides. 2. Determine that a positive score givento participants with AS = 0 is not merely noise, but rather
measures lower levels of true subclinical disease. 3. Deter-
mine that the new score is at least as reproducible as the
AS. We next address how we assessed these three points.
For Point 1, we compared the relationship of the AS and
events to that of the SWCS and events. We observed sta-
tistically significant and strong relationships between the
SWCS and CHD events and risk factors. For the subset of
participants with AS > 0, the relationships between the LP
and risk of events and CAC scores was similar for both
CAC scores, suggesting that the SWCS is replicating the
information in the AS in those participants with AS > 0.
Furthermore, a simple visual examination of the plot (Fig-
ure 1) of each non-zero AS against its corresponding
SWCS suggests very strong correlation between the two
scores. For all participants, and participants with AS > 0,
the R2 values for the SWCS and AS are comparable. We
emphasize that since the goal of our analysis is validation
of the SWCS, the focus should be on R2 as a descriptive
statistic comparing the SWCS and AS rather than as a
measure of predictive accuracy. Nonetheless, the relatively
low R2 values make sense, as the linear regression model
only includes CAC, site, weight, and height. In particular,
when we consider that CAC has been demonstrated to
provide additional predictive information in addition to the
traditional cardiovascular risk factors [8,10,15,16,28,29]
(which were used to construct the linear predictor), it is
unsurprising that the R2 values are not high.
Examining these relationships in participants with AS =
0 addresses Point 2. For all CHD events, a doubling of
SWCS was associated with a hazard ratio of 1.11 (95% CI,
0.79 to 1.55). For CHD risk, we observed a significant as-
sociation between the SWCS and the LP; each unit in-
crease in the log(SWCS + 1) was associated with an
increase in the mean LP of 0.18 (95% CI, 0.14 to 0.22).
The Kaplan-Meier curves for the first two quartiles of the
SWCS show a distinct separation. Furthermore, the 50–
62.5 and 62.5-75.0 percentile curves for the SWCS appear
to be better separated than those of the AS. This suggests
that the SWCS algorithm was in fact detecting additional
useful information, and that the continuous scale repre-
sents a meaningful ordering of CAC suitable for measur-
ing atherosclerotic burden and the attendant risk of CHD
events.
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http://www.biomedcentral.com/1471-2342/12/14To address Point 3, we assessed the reproducibility of
the SWCS in comparison with the AS. Using the percent
difference as a measure of reproducibility, we found that
the median percent difference was 16.87% and 18.29%
for the SWCS and AS, respectively. The intraclass corre-
lations were 0.988 and 0.989 for the SWCS and AS, re-
spectively. Our results suggest that the SWCS is at least
as reproducible as the Agatston score.
There are two main limitations for the SWCS. One
limitation was the lack of a true gold standard for validat-
ing the SWCS. The MESA study is composed of a large
population of asymptomatic individuals and thus cardiac
catheterization (with either angiography or intravascular
ultrasound) was not a practical validation method, as it is
restricted to studies of symptomatic populations or in
treatment trials [18,30-32]. Of course, histologic valid-
ation [1,2] was not an option either. We instead used
prediction of events and risk of events as a surrogate for
a true gold standard, which in itself was limited by the
small number of events in those participants with AS =
0. Furthermore, the emergence of models combining
CAC measures with traditional risk summaries such as
the Framingham risk [28,29] suggests potential for using
alternative, potentially richer models for validation. Re-
gardless of the validation used, it would be useful to per-
form further validation using an independent but
comparable dataset. In particular, separate in vitro ex-
perimental studies to validate SWCS would be highly de-
sirable. Another limitation involves the applicability of
the results outside of the MESA. The SWCS was
designed to be a cost-effective approach to rescoring the
MESA CT images in a less conservative manner than the
original approach to reduce the number of false negatives
(when the CAC score is zero but subclinical disease is in
fact present). To use the approach presented here in
other large studies where comparable calibration phan-
toms were not scanned or tracing the coronary arteries
was not done is not possible.Conclusions
In conclusion, we have developed a new continuous
method of quantifying coronary artery calcium that may
provide a continuous and improved measure of athero-
sclerosis compared to existing coronary artery calcium
scoring methods. This new method is anticipated to be
advantageous in research applications, especially in the
evaluation of genetic and environmental risk factors.Additional file
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